Parra H.
81
Coauthors
7
Documentos
Volumen de publicaciones por año
Cargando gráfico
| Año de publicación | Num. Publicaciones |
|---|---|
| 2021 | 4 |
| 2022 | 3 |
Publicaciones por áreas de conocimiento
Cargando gráfico
| Área de conocimiento | Num. Publicaciones |
|---|---|
| Infección | 2 |
| Medicina interna | 2 |
| Cáncer | 2 |
| Fisiología | 1 |
| Neurología | 1 |
| Neuropsicología | 1 |
| Toxicología | 1 |
| Obesidad | 1 |
| Enfermedad cardiovascular | 1 |
| Bioquímica | 1 |
Publicaciones por áreas temáticas
Cargando gráfico
| Área temática | Num. Publicaciones |
|---|---|
| Enfermedades | 7 |
| Fisiología humana | 4 |
| Farmacología y terapéutica | 3 |
| Psicología aplicada | 1 |
| Medicina y salud | 1 |
Principales fuentes de datos
| Origen | Num. Publicaciones |
|---|---|
| Scopus | 7 |
| Google Scholar | 0 |
| RRAAE | 0 |
Cargando gráfico
Coautores destacados por número de publicaciones
| Coautor | Num. Publicaciones |
|---|---|
| Valmore Bermúdez | 7 |
| Nava M. | 5 |
| González M.C. | 4 |
| D’marco L. | 3 |
| Salazar-Vílchez J. | 3 |
| Dávila L.C.A. | 3 |
| Ortega A. | 3 |
| Díaz-Camargo E.A. | 2 |
| Castro A. | 2 |
| Pírela D. | 2 |
Cargando gráfico
Top Keywords
Cargando gráfico
Publicaciones del autor
SGLT2i and GLP-1RA in Cardiometabolic and Renal Diseases: From Glycemic Control to Adipose Tissue Inflammation and Senescence
ReviewAbstract: Background. Over the last few years, the use of sodium-glucose cotransporter 2 inhibitors (SGLT2i) aPalabras claves:Autores:D’marco L., Morillo V., Nava M., Ortega A., Parra H., Rojas-Quintero J., Suarez M.K., Teruel J.L., Valmore Bermúdez, Villasmil N.Fuentes:scopusThe yap/taz signaling pathway in the tumor microenvironment and carcinogenesis: Current knowledge and therapeutic promises
ReviewAbstract: The yes-associated protein (YAP) and the transcriptional coactivator with PDZ-binding motif (TAZ) arPalabras claves:Carcinogenesis, cell proliferation, Chemoresistance, Drug resistance, Hippo signaling pathway, immunotherapy, Neoplastic stem cells, TEAD, tumor microenvironment, YAP/TAZAutores:de Sanctis J.B., Diaz M.P., Navarro C., Ortega A., Parra H., Rojas M., Salazar-Vílchez J., Torres W., Valmore Bermúdez, Vera I.Fuentes:scopusPathogenic mechanisms of SARS-CoV-2 infection and kidney disease: a clinical and molecular perspective
ArticleAbstract: The SARS-CoV-2 infection has become as a worldwide public health emergency. It exhibits a variety ofPalabras claves:acute kidney injury, Angiotensin-conver-ting enzyme 2, Chronic kidney disease, covid-19, SARS-COV-2Autores:D’marco L., Guerra-Torres X.E., Lameda V., Manzano A., Medina O., Morillo V., Nava M., Parra H., Puchades M.J., Suarez M.K., Torres W., Valmore BermúdezFuentes:scopusHypertension, emotions and happiness: A brief view from the biology to the positive psychology
ArticleAbstract: High blood pressure (HBP) is a silent disease with an extremely high prevalence worldwide. It is conPalabras claves:Cardiovascular disease, happiness, HEALTH, Hypertension, psychosocialAutores:Bautista-Sandoval M.J., Castro A., Chaparro-Suárez Y.K., Díaz-Camargo E.A., Durán P., D’marco L., González M.C., Nava M., Ortiz O.M., Parra H., Riaño-Garzón M.E., Rojas E.R., Valmore BermúdezFuentes:scopusMetabolic syndrome: Is it time to add the central nervous system?
ReviewAbstract: Metabolic syndrome (MS) is a set of cardio-metabolic risk factors that includes central obesity, hypPalabras claves:Alzheimer’s disease, Diabetes mellitus type 2, Insulin Resistance, Metabolic syndrome, Mild cognitive impair-mentAutores:Añez-Ramos R., Chávez-Castillo M., Dávila L.C.A., Díaz-Camargo E.A., Durán-Agüero S., González M.C., Gravini-Donado M., Nava M., Parra H., Pírela D., Rina Ortiz, Rojas M., Salazar-Vílchez J., Valmore BermúdezFuentes:scopus